Welsbach Technology Metals Acquisition Corp. (NASDAQ: WTMA) announced this afternoon that it has signed a non-binding letter of intent (LOI) to combine with an undisclosed target in the critical materials space for, so far, undisclosed terms.
The parties are currently considering the specific terms of the potential business combination, and expect to disclose further details once a definitive agreement is signed.
Today’s announcement comes two weeks before WTMA’s extension vote scheduled for September 28. Shareholders at the special meeting will vote on a proposal to extend the SPAC’s completion deadline up to an additional nine months, from September 30, 2023, to June 30, 2024.
This potential deal marks Welsbach’s second shot at completing a business combination following its termination with battery-maker WaveTech in June, citing market conditions. The deal was valued at $228 million and featured a $25 million minimum cash condition.
Welsbach currently has approximately $37.8 million in its trust after seeing 53.03% redeemed during a meeting in March.
The SPAC has been searching for a combination target in the space of “energy transition metals” like rare earth miners or battery technology firms since its IPO in December 2021. It is led by CEO and Chairman Daniel Mamadou and COO Christopher Clower, both from Singapore-based energy investment firm Welsbach Holdings.
Since this is still just a non-binding LOI, Welsbach Technology Metals will remain in SPACInsider‘s “Searching” column for now.
Aimei Health Technology II Co., Ltd (NASDAQ:AHJKU) has filed for a $60 million SPAC ostensibly to pair up with a small cap biotech or medical device target, but its team’s experience both in SPACs and beyond suggest the vehicle will be open to a broad set of potential targets. It is the first SPAC to...
At the SPAC of Dawn The markets got to open one stocking early yesterday, but it was mostly coal as it showed durable goods orders had declined by more than twice as much as expected to -1.1% in November. It wasn’t all signs of naughtiness, however. Amid the numbers that came public one day earlier...
Copley Acquisition Corp has filed to raise a $150 million SPAC to hunt for a technology or lifestyle target in either the Asia Pacific or North America regions. The new S-1 also advances underwriter Clear Street in the league tables as it has backed two of the three latest SPACs to file in December, and...
Translational Development Acquisition Corp. (NASDAQ: TDACU) announced the pricing of its $150 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “TDACU”, Monday, December 23, 2024. The new SPAC intends to take a generalist approach in searching for a business combination, but intend to focus on industries that...
At the SPAC of Dawn SPACs have set to have a busy holiday week with three business combination approval votes and eight special meetings for extensions. Teams are trying to get eight of these in the books today, including all three completion votes ahead of Christmas Eve tomorrow. As noted last week, the theme of...